Delivery Order SPE2DB22D3301-SPE2DB26FX3JL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,007.92 on September 12, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is competitively awarded with no set-aside designation and features firm fixed pricing, with an ultimate completion date of September 15, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a division of the...
- AmerisourceBergen Drug Corporation, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 27, 2025, for OxyContin ER 20 mg tablets (100-count units) valued at $1,183.01. The contract, which is a firm fixed-price delivery order with no set-aside designation, represents a competitive award under the Defense Logistics Agency's broader pharmaceutical supply framework. The award carries an ultimate completion date of August 28, 2025,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,161.00 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $5,025.57. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by August 12, 2025, with the product to be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of OxyContin Tablets 30mg to the Defense Logistics Agency's Medical Supply Chain. The contract, valued at $1,541.40 with a firm fixed-price structure, carries an ultimate completion date of August 6, 2025, and will be fulfilled at the vendor's Conshohocken, PA facility. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,675.65 on October 16, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract, which is not set-aside and utilizes firm fixed pricing, is scheduled for completion by October 17, 2025, with fulfillment from the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,072.23 for OxyContin tablets (20mg) by the Department of Defense Medical Supply Chain, with an award date of October 5, 2025, and ultimate completion by October 6, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3JLDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,862.64 by the Defense Logistics Agency on October 16, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award through open procurement. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare systems. The delivery order supports the Defense Logistics Agency's critical role in supplying pharmaceutical products to military and veteran healthcare systems across the Department of Defense. AmerisourceBergen's contract portfolio with DLA demonstrates its capability to fulfill federal medical procurement requirements for a wide range of therapeutic products, from brand-name and generic medications to specialized medical supplies. The OxyContin ER delivery represents a routine pharmaceutical replenishment within the company's extensive medical supply chain operations supporting defense healthcare programs, with an ultimate completion date of October 17, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 10/16/25 |